Esperite

Esperite EPS

Delisted

The Earnings per Share (EPS) of Esperite (ESP.AS) as of Nov 16, 2026 is -0.93 EUR. In the previous year, Earnings per Share (EPS) was -0.81 EUR — a change of 14.44% (lower).

EPS

-0.93EUR

YoY

14.44%

Last updated:

Earnings per Share (EPS) of Esperite is 2017 -0.93 EUR. Earnings per Share (EPS) of Esperite was 2016 -0.81 EUR. It decreases by 14.44% lower compared to the previous year.

The Esperite EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2010
0.28 EUR
Jan 1, 2011
0.25 EUR
Jan 1, 2012
-1.83 EUR
Jan 1, 2013
-0.38 EUR
Jan 1, 2014
-0.52 EUR
Jan 1, 2015
-0.70 EUR
Jan 1, 2016
-0.81 EUR
Jan 1, 2017
-0.93 EUR
The Esperite EPS history
YEAREPSYoY
-0.93EUR+14.44%
-0.81EUR+15.38%
-0.70EUR+36.50%
-0.52EUR+35.87%
-0.38EUR-79.28%
-1.83EUR-833.93%
0.25EUR-9.31%
0.28EUR+88.28%
0.15EUR-46.62%
0.27EUR-46.88%
0.52EUR+143.49%
0.21EUR-13.19%
0.24EUR-735.14%
-0.04EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Esperite Stock analysis

What does Esperite do? Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Esperite stock

Earnings per Share (EPS) of Esperite is -0.93 EUR in 2017.

Earnings per Share (EPS) of Esperite changed from -0.81 EUR to -0.93 EUR, representing a 14.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Esperite since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Esperite

All Key Metrics — Esperite